ICER Report: Costs of Approved CAR T-Cell Therapies Aligned With Clinical Benefit – AJMC.com Managed Markets Network
|
ICER Report: Costs of Approved CAR T-Cell Therapies Aligned With Clinical Benefit
AJMC.com Managed Markets Network CAR T-cell therapy has emerged as a novel way to treat cancer, genetically reprogramming a patient's own white blood cells to attack tumor cells, and was recently named the American Society of Clinical Oncology's Advance of the Year. Earlier this month … |
